Literature DB >> 6834277

Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol.

G DiMinno, M J Silver.   

Abstract

We present a simple method for screening antithrombotic agents. When male Swiss-Webster mice (25-34 g; N = 143) were given an i.v. injection of 0.1 ml of a mixture of collagen (dose, 15 micrograms/mouse) and epinephrine (dose, 1.8 micrograms/mouse), 94% died within 5 min or remained paralyzed for more than 15 min. Examples of the use of the system for the study of antithrombotic agents are given. Solutions of agents were administered to the animals i.p. about 1 hr before the thrombotic challenge. Aspirin (20 mg/kg), OKY-1581 (30 mg/kg) and ethanol (2 gm/kg), administered as single agents in aqueous medium, protected (P less than .01, chi 2 test) 40, 50 and 35% of the animals, respectively. Heparin (150 U/kg) was ineffective. Combinations of ethanol with indomethacin or indobufen provided complete protection, whereas ethanol plus aspirin protected 84% of the animals and ethanol plus OKY-1581 protected 70% of the animals. Dipyridamole alone (3 mg/kg), dipyridamole (1.65 mg/kg) plus ethanol or dipyridamole (1.65 mg/kg) plus aspirin were ineffective. The method appears well suited for screening potential antithrombotic agents which act primarily against platelet thromboembolism.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6834277

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  30 in total

1.  Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs.

Authors:  J Yang; J Wu; M A Kowalska; A Dalvi; N Prevost; P J O'Brien; D Manning; M Poncz; I Lucki; J A Blendy; L F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

2.  Effects of indobufen on platelet thromboxane B2 production in patients with myocardial infarction.

Authors:  A G Rebuzzi; A Natale; C Bianchi; F Mariello; E Coppola; G Ciabattoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation.

Authors:  Brian G Petrich; Per Fogelstrand; Anthony W Partridge; Nima Yousefi; Ararat J Ablooglu; Sanford J Shattil; Mark H Ginsberg
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  The isothiocyanate sulforaphane modulates platelet function and protects against cerebral thrombotic dysfunction.

Authors:  Scarlett Gillespie; Paul M Holloway; Felix Becker; Francesca Rauzi; Shantel A Vital; Kirk A Taylor; Karen Y Stokes; Michael Emerson; Felicity N E Gavins
Journal:  Br J Pharmacol       Date:  2018-07-03       Impact factor: 8.739

Review 5.  Prevention of cardiovascular risk by moderate alcohol consumption: epidemiologic evidence and plausible mechanisms.

Authors:  Augusto Di Castelnuovo; Simona Costanzo; Maria Benedetta Donati; Licia Iacoviello; Giovanni de Gaetano
Journal:  Intern Emerg Med       Date:  2010-02-03       Impact factor: 3.397

6.  Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy.

Authors:  Anne Angelillo-Scherrer; Laurent Burnier; Nathalie Flores; Pierre Savi; Maria DeMol; Paul Schaeffer; Jean-Marc Herbert; Greg Lemke; Stephen P Goff; Glenn K Matsushima; H Shelton Earp; Christian Vesin; Marc F Hoylaerts; Stéphane Plaisance; Désiré Collen; Edward M Conway; Bernhard Wehrle-Haller; Peter Carmeliet
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

7.  Determinants of the thrombogenic potential of multiwalled carbon nanotubes.

Authors:  Andrew R Burke; Ravi N Singh; David L Carroll; John D Owen; Nancy D Kock; Ralph D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Biomaterials       Date:  2011-06-12       Impact factor: 12.479

8.  Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1.

Authors:  Margitta Elvers; David Stegner; Ina Hagedorn; Christoph Kleinschnitz; Attila Braun; Marijke E J Kuijpers; Michael Boesl; Qin Chen; Johan W M Heemskerk; Guido Stoll; Michael A Frohman; Bernhard Nieswandt
Journal:  Sci Signal       Date:  2010-01-05       Impact factor: 8.192

9.  The effect of defibrotide on thromboembolism in the pulmonary vasculature of mice and rabbits and in the cerebral vasculature of rabbits.

Authors:  W Paul; P Gresele; S Momi; G Bianchi; C P Page
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

10.  Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency.

Authors:  Jing Zhang; Yizheng Tu; Lan Lu; Nina Lasky; George J Broze
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.